Want to create an interactive transcript for this episode?
Podcast: WCG Talks Trials
Episode: Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
Description: In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCGās President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.Ā